Z-1359-2019 Class III Terminated

Recalled by Abbott Laboratories — Abbott Park, IL

FDA device recall Z-1359-2019 was initiated by Abbott Laboratories on Apr 9, 2019 and is designated Class III. Reason for recall: Devices were delivered without the required dry ice. The recall status is terminated (terminated Dec 20, 2019). Affected quantity: 2 units.

Recall details

Product Type
Devices
Report Date
May 22, 2019
Initiation Date
Apr 9, 2019
Termination Date
Dec 20, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2 units

Product description

ARCHITECT STAT High Sensitive Troponin-I Controls - Product Usage: The ARCHITECT STAT High Sensitive Troponin-I Controls are for the estimation of test precision and the detection of systematic analytical deviations of the ARCHITECT i System with STAT protocol capability when used for the quantitative determination of cardiac troponin I (cTnI) in human serum and plasma with the ARCHITECT STAT High Sensitive Troponin-I reagent kit.

Reason for recall

Devices were delivered without the required dry ice.

Distribution pattern

Distribution to Latvia.

Code information

LN 3P25-11; Lot 94347UIOO

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1359-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1359-2019. Report a data issue: hello@regdatalab.com.